glp 1 and medicaid Coverage of Spending on GLP-1s GLP-1s and The Payer Predicament

Explore the intersection of GLP-1 therapies and gut health to manage metabolic dysfunction and support patient wellness.

A new class of drugs is reshaping global health,but Indias generics wave could change who benefits

Harvard geneticist David Sinclair reveals a rare but serious blindness risk linked to GLP-1 drugs, estimating 20,00030,000 NAION cases per year in

(the intracellular action meCHAnism of incretin) () 1

Resveratrol & Magnesium Provide antioxidant support & contribute to overall well-being

Methods In this open-label, single-center, casecontrol pilot study, patients with IIH (pwIIH) and a body mass index (BMI) of30 kg/m2 were offered to receive a GLP-1-RA (semaglutide, liraglutide) in addition to the usual care weight management (UCWM)